Ünver, SuatHaholu, AptullahYıldırım, Sukru2024-07-122024-07-1220212048-85052048-851310.1093/ckj/sfab1552-s2.0-85119493424https://doi.org/10.1093/ckj/sfab155https://hdl.handle.net/20.500.12415/7163A 67-year-old female with Type 2 diabetes mellitus developed nephrotic syndrome within 1 week of receiving the first dose of severe acute respiratory syndrome coronavirus 2 CoronaVac vaccine. A kidney biopsy was consistent with minimal change nephrotic syndrome and treatment was symptomatic with antiproteinuric therapy and improvement in proteinuria. Oedema returned within 1 week of the second dose of CoronaVac. On this occasion, acute kidney injury and massive proteinuria were noted. In kidney biopsy, glomeruli were normal, but tubulointerstitial inflammation consistent with acute tubulointerstitial nephritis was noted. Pulse followed by oral steroids was followed by recovery of kidney function. Proteinuria decreased after initiation of cyclosporine A.eninfo:eu-repo/semantics/openAccessAcute Interstitial NephritisAcute Kidney InjuryCovid-19 VaccinationKidney BiopsyMinimal Change DiseaseNephrotic SyndromeProteinuriaArticle26111234938535Q1260814WOS:000736068200018Q1